NPS MedicineWise is funded by the Australian Government Department of Health through the Quality Use of Diagnostics, Therapeutics and Pathology Program to improve the way medicines and medical tests are prescribed and used (QUM grant).
Dementia and changed behaviours: a person-centred approach aims to improve the management of behavioural and psychological symptoms (BPSD) of dementia in people aged ≥ 65 years by supporting person-centred approaches caring for people with dementia in the community and in aged care facilities. The program has been developed in consultation with key stakeholders in aged care including the Aged Care Quality and Safety Commission and the Aged Care Division of the Australian Government Department of Health.
Program facts and figures
- Program delivery: September 2020 – September 2021
- Educational visits to GPs in primary care from 1 October – 31 December 2020: 2013
- Educational visits in Residential Aged Care Facilities to nurse champions & pharmacists from 1 October – 31 December 2020: 108
- Pre-program estimated PBS savings: $1.3 million per annum
- Program costs Financial Year 2020-21: $3,382,599
Health professional resources
- Program landing page: Dementia and psychotropic medicines
- Educational visits for GPs (CPD accredited)
- RACF education package for nurse champions & pharmacists (CPD accredited)
- Webinars (CPD accredited*):
- Clinical tools and resources:
- Related publications and podcasts:
- Australian Prescriber: limiting antipsychotic drugs in dementia
- Australian Prescriber: deprescribing in older people – article and podcast
- RADAR article: Revised PBS restrictions for behavioural and psychological symptoms of dementia
* Note: CPD accreditation is only available for webinars attended live. Viewing of the webinar recording can be self-recorded as CPD.
Consumer resources
- Consumer factsheet & behaviour diary: Dementia and changed behaviours: a plan for you and your carers
- MedicineWise app
- Medicines and dementia: what you need to know